|
STXBP4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.97299999999246E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.464420E-03 |
| Normal-vs-Stage2 |
2.484000E-01 |
| Normal-vs-Stage3 |
1.34929999950906E-07 |
| Normal-vs-Stage4 |
2.12999995419239E-09 |
| Stage1-vs-Stage2 |
8.204500E-02 |
| Stage1-vs-Stage3 |
1.145970E-02 |
| Stage1-vs-Stage4 |
8.14900000000174E-05 |
| Stage2-vs-Stage3 |
4.009100E-04 |
| Stage2-vs-Stage4 |
1.9521999999994E-05 |
| Stage3-vs-Stage4 |
1.411640E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.81590999999148E-05 |
| Normal-vs-AfricanAmerican |
2.814200E-02 |
| Normal-vs-Asian |
3.004000E-03 |
| Caucasian-vs-AfricanAmerican |
4.132200E-01 |
| Caucasian-vs-Asian |
6.958400E-01 |
| AfricanAmerican-vs-Asian |
6.555000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.33889999999848E-05 |
| Normal-vs-Female |
2.045900E-04 |
| Male-vs-Female |
3.427200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.004180E-03 |
| Normal-vs-Age(41-60Yrs) |
1.157380E-04 |
| Normal-vs-Age(61-80Yrs) |
8.4713000000014E-05 |
| Normal-vs-Age(81-100Yrs) |
6.777300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.640600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.442200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.417400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.899600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.680400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.651000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.56280000000498E-05 |
| Classical-VS-Follicular |
4.903600E-02 |
| Classical-VS-Other |
7.137800E-01 |
| Classical-VS-Normal |
1.007280E-04 |
| Tall-VS-Follicular |
2.5689999999523E-06 |
| Tall-VS-Other |
1.384810E-01 |
| Tall-VS-Normal |
1.32379995854137E-09 |
| Follicular-VS-Other |
3.487200E-01 |
| Follicular-VS-Normal |
8.534500E-02 |
| Other-VS-Normal |
4.239800E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.393600E-04 |
| Normal-vs-N1 |
2.99230000000428E-07 |
| N0-vs-N1 |
5.295100E-03 |
|
|
